From the Department of Anesthesiology, Brigham and Women's Hospital, Boston, Massachusetts.
Department of Anesthesiology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, New York.
Anesth Analg. 2022 Nov 1;135(5):944-953. doi: 10.1213/ANE.0000000000006076. Epub 2022 Aug 26.
Cardiac valvular disease affects millions of people worldwide and is a major cause of morbidity and mortality. Female patients have been shown to experience inferior clinical outcomes after nonvalvular cardiac surgery, but recent data are limited regarding open valve surgical cohorts. The primary objective of our study was to assess whether female sex is associated with increased in-hospital mortality after open cardiac valve operations.
Utilizing the Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases (SID), we conducted a retrospective cohort study of patients who underwent open cardiac valve surgery from 2007 to 2018 in Washington, Maryland, Kentucky, and Florida; from 2007 to 2011 in California; and from 2007 to 2016 in New York. The primary objective of this study was to estimate the confounder-adjusted association between sex and in-hospital mortality (as recorded and coded by SID HCUP) after open cardiac valve surgery. We used multilevel multivariable models to account for potential confounders, including intrahospital practice patterns.
A total of 272,954 patients (108,443 women; 39.73% of sample population with mean age of 67.6 ± 14.3 years) were included in our analysis. The overall mortality rates were 3.8% for male patients and 5.1% for female patients. The confounder-adjusted odds ratio (OR) for in-hospital mortality for female patients compared to male patients was 1.41 (95% confidence interval [CI], 1.35-1.47; P < .001). When stratifying by surgical type, female patients were also at increased odds of in-hospital mortality ( P < .001) in populations undergoing aortic valve replacement (adjusted OR [aOR], 1.38; 95% CI, 1.25-1.52); multiple valve surgery (aOR, 1.38; 95% CI, 1.22-1.57); mitral valve replacement (aOR, 1.22; 95% CI, 1.12 - 1.34); and valve surgery with coronary artery bypass grafting (aOR, 1.64; 95% CI, 1.54 - 1.74; all P < .001). Female patients did not have increased odds of in-hospital mortality in populations undergoing mitral valve repair (aOR, 1.26; 95% CI, 0.98 - 1.64; P = .075); aortic valve repair (aOR, 0.87; 95% CI, 0.67 - 1.14; P = .32); or any other single valve repair (aOR, 1.10; 95% CI, 0.82 - 1.46; P = .53).
We found an association between female patients and increased confounder-adjusted odds of in-hospital mortality after open cardiac valve surgery. More research is needed to better understand and categorize these important outcome differences. Future research should include observational analysis containing granular and complete patient- and surgery-specific data.
全球有数百万患有心脏瓣膜疾病的人,心脏瓣膜疾病是发病率和死亡率的主要原因。女性患者在接受非瓣膜性心脏手术后的临床预后较差,但最近关于开放性心脏瓣膜手术队列的数据有限。我们的主要研究目的是评估女性性别是否与开放性心脏瓣膜手术后院内死亡率增加有关。
我们利用医疗保健成本和利用项目(HCUP)州际住院数据库(SID),对 2007 年至 2018 年期间在华盛顿州、马里兰州、肯塔基州和佛罗里达州;2007 年至 2011 年期间在加利福尼亚州;2007 年至 2016 年期间在纽约州进行开放性心脏瓣膜手术的患者进行回顾性队列研究。本研究的主要目的是估计性别与开放性心脏瓣膜手术后院内死亡率(由 SID HCUP 记录和编码)之间的混杂因素调整关联。我们使用多水平多变量模型来解释潜在的混杂因素,包括院内手术实践模式。
共纳入 272954 例患者(女性 108443 例;样本人群的平均年龄为 67.6±14.3 岁,占 39.73%)。男性患者的总体死亡率为 3.8%,女性患者的死亡率为 5.1%。与男性患者相比,女性患者院内死亡率的混杂因素调整比值比(OR)为 1.41(95%置信区间[CI],1.35-1.47;P<0.001)。按手术类型分层,女性患者在接受主动脉瓣置换术(调整 OR[aOR],1.38;95%CI,1.25-1.52);多瓣膜手术(aOR,1.38;95%CI,1.22-1.57);二尖瓣置换术(aOR,1.22;95%CI,1.12-1.34);和冠状动脉旁路移植术联合瓣膜手术(aOR,1.64;95%CI,1.54-1.74;所有 P<0.001)时,也更有可能出现院内死亡。女性患者在接受二尖瓣修复术(aOR,1.26;95%CI,0.98-1.64;P=0.075);主动脉瓣修复术(aOR,0.87;95%CI,0.67-1.14;P=0.32);或任何其他单一瓣膜修复术(aOR,1.10;95%CI,0.82-1.46;P=0.53)时,院内死亡率的调整 OR 没有增加。
我们发现女性患者与开放性心脏瓣膜手术后院内死亡率增加之间存在关联。需要进一步研究以更好地理解和分类这些重要的结果差异。未来的研究应包括包含详细和完整的患者和手术特定数据的观察性分析。